Natera, Inc. NTRA
Natera, Inc. is a diagnostics company that develops and commercializes genetic testing solutions using proprietary molecular and bioinformatics technology. The company focuses on three main healthcare areas: women's health, oncology, and organ health. Its core technology analyzes cell-free DNA (cfDNA) from blood samples to detect genetic variations associated with various conditions, enabling non-invasive or minimally invasive testing for prenatal screening, cancer monitoring, and transplant rejection assessment. Natera serves healthcare providers and patients globally through a combination of a direct sales force in the United States and a network of over 100 laboratory and distribution partners worldwide. The company operates a cloud-based platform called Constellation, which allows partner laboratories to run tests locally while accessing its algorithms remotely. Natera emphasizes generating clinical evidence through peer-reviewed research and maintains a strong intellectual property portfolio with hundreds of patents.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.